Picture of Initiator Pharma A/S logo

INIT Initiator Pharma A/S News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Initiator Pharma Completes Preclinical Studies For Development Of Candidate IPED2015

Jan 22 (Reuters) - INITIATOR PHARMA A/S  INIT.TE : 
    * SUCCESFULLY COMPLETES PRECLINICAL STUDIES FOR DEVELOPMENT 
OF 
CANDIDATE IPED2015 
    * IT IS ANTICIPATED THAT IPED2015 WILL QUALIFY AS A CLINICAL 
CANDIDATE 
 
Source text for Eikon:  ID:nWkr81jkpk  
Further company coverage:  INIT.TE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 587720920;))

Recent news on Initiator Pharma A/S

See all news